Chronic Disease Management through Regenerative Medicine

Stem cell research is a rapidly growing and diversifying field of study that is generating tremendous advances in our understanding of disease and our capacity to curechronic diseases. The Center for Regenerative Medicine at Massachusetts General Hospital strives to bridge the gap between basic science and the clinical setting. We are working to develop therapies that can be applied to the treatment of chronic diseases such as leukemia, lymphoma, various cancers, diabetes, and other illnesses rooted in tissue damage. Stem cell research has already resulted in remarkable progress in bone marrow transplantation, saving thousands of lives over the past four decades. Expanding those successes into the treatments for other serious diseases is our vision and the goal of stem cell research at the Center for Regenerative Medicine.

Every day, some of the world’s most talented scientists come to work in the labs at the Center for Regenerative Medicine. These researchers are talented, driven, and creative in their strategies for understanding the cellular basis of disease and mechanisms for tissue regeneration. Many of our investigators hold MD and PhD degrees from top universities and our trainees, fellows, and students have exceptional backgrounds in genetics, cancer biology, biochemistry, cell biology and others.

Dr. Scadden’s role as Co-Director of the Harvard Stem Cell Institute has contributed to the strong partnership between the Center for Regenerative Medicine and Harvard University. The Center for Regenerative Medicine is also an active participant in the network of Core Facilities sponsored by the HSCI. Through the involvement and support of the entire community, we can move towards a powerful new means of conducting regenerative and reparative medical research, driven by increased communication and collaboration and directed toward novel chronic disease treatments to improve patient care.